Products
Our Product
Trusted Medication for Your Health & Wellness.
Rosuvagen
Treatment of Hypercholesterolaemia
- Adults, adolescents, and children aged 6 years or older with primary hypercholesterolaemia (type IIa, including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) may use this medication as an adjunct to diet when the response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate.
- Homozygous familial hypercholesterolaemia may require this medication as an adjunct to diet and other lipid-lowering treatments (e.g., LDL apheresis), or if such treatments are not appropriate.
Prevention of Cardiovascular Events
- To prevent major cardiovascular events in patients estimated to be at high risk for a first cardiovascular event, this medication is used as an adjunct to correcting other risk factors.
- Hypersensitivity to any component of this product. Patients with active liver disease including unexplained, persistent elevations of serum transaminases, and any serum transaminase elevation exceeding 3 times the upper limit of normal (ULN). During pregnancy and lactation.Patient receiving concomitant combination of Sofosbuvir/Velpatasvir/ Voxilaprevir and concomitant cyclosporine.
- Rosuvagen Rosuvastatin 10mg: in boxes 28 tablets (2 blisters × 14 tablets).
- Rosuvagen Rosuvastatin 20 mg: in boxes 28 tablets (4 blisters × 7 tablets).
- Rosuvagen Rosuvastatin 10 mg: Each tablet contains 10 mg rosuvastatin (as rosuvastatin calcium). Each tablet contains 90.283 mg lactose.
- Rosuvagen Rosuvastatin 20 mg: Each tablet contains 20 mg rosuvastatin (as rosuvastatin calcium). Each tablet contains 180.566 mg lactose.
- Activ Pharma Sdn. Bhd.
Drug Information
- The information provided on this website is intended for informational purposes only and does not substitute professional medical advice. While we make every effort to ensure that the information is accurate and up-to-date, we acknowledge that the drug information may be subject to changes and updates regularly. Therefore, we alert our users that the drug information provided may not always be up-to-date. We recommend that users consult additional sources, such as qualified healthcare professionals or reliable sources of drug information, to access the most recent and accurate information about specific medications.
Etorigen
-
- Etorigen is indicated for the symptomatic relief of osteoarthritis (OA), rheumatoid arthritis (RA), ankylosing spondylitis, and the pain and signs of inflammation associated with acute gouty arthritis in adults and adolescents 16 years of age and older
- Etorigen is indicated for the short-term treatment of moderate pain associated with dental surgery in adults and adolescents 16 years of age and older.
- The decision to prescribe a selective COX-2 inhibitor should be based on an assessment of the individual patient’s overall risks (see ‘Contraindications’ and ‘Warnings and precautions’ ).
Hypersensitivity to any component of this product. Congestive heart failure. Established ischemic heart disease peripheral arterial disease and/or cerebrovascular disease. Pregnancy. Hypertension. Patient with active gastrointestinal ulceration or bleeding.
- Etorigen 90 mg film-coated tablets: Pack sizes of 4 × 7’s film-coated tablets
- Etorigen 120 mg film-coated tablets: Pack sizes of 4 × 7’s film-coated tablets
- Etorigen 90 mg: Each film-coated tablet contains 90 mg Etoricoxib. Each tablet contains 3.15 mg lactose (as monohydrate).
- Etorigen 120 mg: Each film-coated tablet contains 120 mg Etoricoxib. Each tablet contains 4.20 mg lactose (as monohydrate).
- Activ Pharma Sdn. Bhd.
Drug Information
- The information provided on this website is intended for informational purposes only and does not substitute professional medical advice. While we make every effort to ensure that the information is accurate and up-to-date, we acknowledge that the drug information may be subject to changes and updates regularly.Therefore, we alert our users that the drug information provided may not always be up-to-date. We recommend that users consult additional sources, such as qualified healthcare professionals or reliable sources of drug information, to access the most recent and accurate information about specific medications.
Let's Connect!
Have a question or need support? We’re here to help. Reach out to us and let’s work together towards better healthcare.
